Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associa ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associa ...

S&G PROPERTIES MANAGEMENT, with Lee & Associates' help, acquires a 62K sq. ft. L.A. office building to occupy and upgrade.

Nutrition 101 announced the acquisition of Value Feeds with strategic supply contracts from the region's leading dairy ...

Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.

The Oklahoma City Thunder avoided a letdown with a 101-94 win over the Dallas Mavericks on Monday. After building a 22-point lead, they were suddenly in a one-point contest in the final moments. Shai ...

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

Abstract: This study investigates the transformative impact of artificial intelligence (AI) on human resource management (HRM) practices through a quantitative descriptive approach. Data were ...